Prognostic Value of the Neutrophil to Lymphocyte Ratio (NLR) in Lung Cancer Cases
- PMID: 28612596
- PMCID: PMC5555556
- DOI: 10.22034/APJCP.2017.18.5.1417
Prognostic Value of the Neutrophil to Lymphocyte Ratio (NLR) in Lung Cancer Cases
Abstract
Haemogram assessment is a cheap and easy method which can be readily performed for almost all patients. Leucocyte, neutrophil and lymphocyte counts and the neutrophil to lymphocyte ratio (NLR) are markers of systemic inflammation. We here aimed to evaluate haemogram parameters of our patients with lung cancer according to the pathologic diagnosis of small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). Materials and Methods: The study included 386 patients diagnosed with lung cancer in our hospital between January 2006 and January 2014. A retrospective examination was made of the data from the patient records and the hospital information. NLR values were categorised into two groups: <3 and ≥3. Results: Median survival time in patients aged <65 years was 28.7 months and in those aged ≥65 years, it was 18.4 months (p<0.001). The median survival time was 20.2 months in NSCLC and 13.0 months in SCLC patients (p<0.001). In NSCLC cases with NLR<3 the median survival time (31.1 months) was longer than that of patients with NLR≥3 (18 months) (p=0.003). In SCLC patients, no relationship could be found between NLR and median survival time (p=0.408). With every 1 unit increase in lymphocyte count a 5.5% decrease in risk of periodic death ((1/0.947)x100=5.5%) was noted. Conclusion: The results of this study demonstrated that lymphocyte count, neutrophil count, Hb, Htc, and NLR are useful in determining prognosis in lung cancer (LC) patients and NLR could be more significant in determining the prognosis in NSCLC than in SCLC cases.
Keywords: Lung cancer; haemogram; neutrophil to lymphocyte ratio (NLR).
Creative Commons Attribution License
Similar articles
-
Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non-small cell lung cancer patients.Thorac Cancer. 2015 May;6(3):275-87. doi: 10.1111/1759-7714.12178. Epub 2015 Apr 24. Thorac Cancer. 2015. PMID: 26273373 Free PMC article.
-
[Neutrophil-to-lymphocyte ratio predicts the survival in patients with post-operative recurrence of non-small cell lung cancer].Zhonghua Zhong Liu Za Zhi. 2014 Apr;36(4):298-302. Zhonghua Zhong Liu Za Zhi. 2014. PMID: 24989918 Chinese.
-
Clinical significance of preoperative neutrophil-lymphocyte vs platelet-lymphocyte ratio in primary operable patients with non-small cell lung cancer.Am J Surg. 2015 Sep;210(3):526-35. doi: 10.1016/j.amjsurg.2015.03.022. Epub 2015 Jun 1. Am J Surg. 2015. PMID: 26105800
-
Neutrophil-to-lymphocyte ratio in occlusive vascular diseases: the literature review of the past 10 years.World J Emerg Med. 2016;7(3):165-72. doi: 10.5847/wjem.j.1920-8642.2016.03.001. World J Emerg Med. 2016. PMID: 27547274 Free PMC article. Review.
-
Neutrophil-to-lymphocyte ratio in ocular diseases: a systematic review.Int J Ophthalmol. 2019 Dec 18;12(12):1951-1958. doi: 10.18240/ijo.2019.12.18. eCollection 2019. Int J Ophthalmol. 2019. PMID: 31850181 Free PMC article. Review.
Cited by
-
Prognostic significance of systemic inflammatory markers in esophageal cancer: Systematic review and meta-analysis.Ann Gastroenterol Surg. 2019 Oct 21;4(1):56-63. doi: 10.1002/ags3.12294. eCollection 2020 Jan. Ann Gastroenterol Surg. 2019. PMID: 32021959 Free PMC article. Review.
-
Adrenergic Signaling in Immunotherapy of Cancer: Friend or Foe?Cancers (Basel). 2021 Jan 21;13(3):394. doi: 10.3390/cancers13030394. Cancers (Basel). 2021. PMID: 33494360 Free PMC article. Review.
-
Predictive value of dynamic changes in peripheral blood inflammation and blood lipid-related indices for the lung cancer treatment efficacy.Am J Cancer Res. 2024 Jun 15;14(6):3130-3141. doi: 10.62347/JOVT3911. eCollection 2024. Am J Cancer Res. 2024. PMID: 39005676 Free PMC article.
-
Longitudinal analysis of blood markers reveals progressive loss of resilience and predicts human lifespan limit.Nat Commun. 2021 May 25;12(1):2765. doi: 10.1038/s41467-021-23014-1. Nat Commun. 2021. PMID: 34035236 Free PMC article.
-
Prognostic value of the neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratio in breast cancer patients.Oncol Lett. 2019 Dec;18(6):6275-6283. doi: 10.3892/ol.2019.10966. Epub 2019 Oct 8. Oncol Lett. 2019. PMID: 31788105 Free PMC article.
References
-
- Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in patients with cancer:a systemic, quantitative review. Cancer. 2001;91:2214, 21. - PubMed
-
- Cedres S, Torrejon D, Martınez A, et al. Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer. Clin Transl Oncol. 2012;14:864, 9. - PubMed